146 related articles for article (PubMed ID: 8706011)
1. Phase II enzyme expression in rat liver in response to the antiestrogen tamoxifen.
Nuwaysir EF; Daggett DA; Jordan VC; Pitot HC
Cancer Res; 1996 Aug; 56(16):3704-10. PubMed ID: 8706011
[TBL] [Abstract][Full Text] [Related]
2. Gene-specific oligonucleotide probes for alpha, mu, pi, and microsomal rat glutathione S-transferases: analysis of liver transferase expression and its modulation by hepatic enzyme inducers and platinum anticancer drugs.
Waxman DJ; Sundseth SS; Srivastava PK; Lapenson DP
Cancer Res; 1992 Oct; 52(20):5797-802. PubMed ID: 1394205
[TBL] [Abstract][Full Text] [Related]
3. Intermittent dosing with oltipraz: relationship between chemoprevention of aflatoxin-induced tumorigenesis and induction of glutathione S-transferases.
Primiano T; Egner PA; Sutter TR; Kelloff GJ; Roebuck BD; Kensler TW
Cancer Res; 1995 Oct; 55(19):4319-24. PubMed ID: 7671242
[TBL] [Abstract][Full Text] [Related]
4. Gadolinium chloride inhibition of rat hepatic microsomal epoxide hydrolase and glutathione S-transferase gene expression.
Kim SG; Choi SH
Drug Metab Dispos; 1997 Dec; 25(12):1416-23. PubMed ID: 9394032
[TBL] [Abstract][Full Text] [Related]
5. Effects of tamoxifen administration on the expression of xenobiotic metabolizing enzymes in rat liver.
Nuwaysir EF; Dragan YP; Jefcoate CR; Jordan VC; Pitot HC
Cancer Res; 1995 Apr; 55(8):1780-6. PubMed ID: 7712488
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional control of glutathione S-transferase gene expression by the chemoprotective agent 5-(2-pyrazinyl)-4-methyl-1,2-dithiole-3-thione (oltipraz) in rat liver.
Davidson NE; Egner PA; Kensler TW
Cancer Res; 1990 Apr; 50(8):2251-5. PubMed ID: 2317812
[TBL] [Abstract][Full Text] [Related]
7. Identification of glutathione S-transferase isozymes and gamma-glutamylcysteine synthetase as negative acute-phase proteins in rat liver.
Buetler TM
Hepatology; 1998 Dec; 28(6):1551-60. PubMed ID: 9828219
[TBL] [Abstract][Full Text] [Related]
8. Induction of hepatic glutathione S-transferase and UDP-glucuronosyltransferase activities by ketamine in rats.
Chan WH; Su HC; Hung MH; Sun WZ; Fan SZ; Hsiao PN; Ueng TH
Acta Anaesthesiol Taiwan; 2008 Mar; 46(1):2-7. PubMed ID: 18390394
[TBL] [Abstract][Full Text] [Related]
9. Suppression of xenobiotic-metabolizing enzyme expression in rats by acriflavine, a protein kinase C inhibitor. Effects on epoxide hydrolase, glutathione S-transferases, and cytochromes p450.
Kim SG; Cho JY; Chung YS; Ahn ET; Lee KY; Han YB
Drug Metab Dispos; 1998 Jan; 26(1):66-72. PubMed ID: 9443855
[TBL] [Abstract][Full Text] [Related]
10. Regulation of gene expression of various phase I and phase II drug-metabolizing enzymes by tamoxifen in rat liver.
Hellriegel ET; Matwyshyn GA; Fei P; Dragnev KH; Nims RW; Lubet RA; Kong AN
Biochem Pharmacol; 1996 Nov; 52(10):1561-8. PubMed ID: 8937471
[TBL] [Abstract][Full Text] [Related]
11. Sex-dependent expression and growth hormone regulation of class alpha and class mu glutathione S-transferase mRNAs in adult rat liver.
Srivastava PK; Waxman DJ
Biochem J; 1993 Aug; 294 ( Pt 1)(Pt 1):159-65. PubMed ID: 8363567
[TBL] [Abstract][Full Text] [Related]
12. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
13. Male-specific suppression of hepatic microsomal UDP-glucuronosyl transferase activities toward sex hormones in the adult male rat administered bisphenol A.
Shibata N; Matsumoto J; Nakada K; Yuasa A; Yokota H
Biochem J; 2002 Dec; 368(Pt 3):783-8. PubMed ID: 12230427
[TBL] [Abstract][Full Text] [Related]
14. Effects of triethyl lead administration on the expression of glutathione S-transferase isoenzymes and quinone reductase in rat kidney and liver.
Daggett DA; Nuwaysir EF; Nelson SA; Wright LS; Kornguth SE; Siegel FL
Toxicology; 1997 Feb; 117(1):61-71. PubMed ID: 9020200
[TBL] [Abstract][Full Text] [Related]
15. Sex differences in the activation of tamoxifen to DNA binding species in rat liver in vivo and in rat hepatocytes in vitro: role of sulfotransferase induction.
Davis W; Hewer A; Rajkowski KM; Meinl W; Glatt H; Phillips DH
Cancer Res; 2000 Jun; 60(11):2887-91. PubMed ID: 10850433
[TBL] [Abstract][Full Text] [Related]
16. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
Marsman D
Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
[TBL] [Abstract][Full Text] [Related]
17. Endocrine factors modulate the phenobarbital-mediated induction of cytochromes P450 and phase II enzymes in a similar strain-dependent manner.
Ganem LG; Jefcoate CR
Toxicol Appl Pharmacol; 1998 May; 150(1):68-75. PubMed ID: 9630454
[TBL] [Abstract][Full Text] [Related]
18. Effects of hydrazine, phenelzine, and hydralazine treatment on rat hepatic and renal drug-metabolizing enzyme expression.
Runge-Morris M; Feng Y; Zangar RC; Novak RF
Drug Metab Dispos; 1996 Jul; 24(7):734-7. PubMed ID: 8818569
[TBL] [Abstract][Full Text] [Related]
19. Phenobarbital at low dose exerts hormesis in rat hepatocarcinogenesis by reducing oxidative DNA damage, altering cell proliferation, apoptosis and gene expression.
Kinoshita A; Wanibuchi H; Morimura K; Wei M; Shen J; Imaoka S; Funae Y; Fukushima S
Carcinogenesis; 2003 Aug; 24(8):1389-99. PubMed ID: 12807726
[TBL] [Abstract][Full Text] [Related]
20. The effects of diquat and ciprofibrate on mRNA expression and catalytic activities of hepatic xenobiotic metabolizing and antioxidant enzymes in rat liver.
Gallagher EP; Buetler TM; Stapleton PL; Wang C; Stahl DL; Eaton DL
Toxicol Appl Pharmacol; 1995 Sep; 134(1):81-91. PubMed ID: 7676460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
